Cataract Surgery Is Covered Until the Surgeon Says “Premium Lens.” That One Word Costs About $3,000 an Eye.

Photo of Gerelyn Terzo
By Gerelyn Terzo Published

Quick Read

  • Medicare covers standard cataract surgery and a monofocal lens, but premium multifocal or toric IOL upgrades cost between $1,500 and $3,000 per eye and Medicare will not pay a dollar of that cost.

  • Neither Medigap Plan G nor most Medicare Advantage plans cover the upgrade, leaving patients with up to $6,000 entirely out of pocket for both eyes.

  • Ask your surgeon for the standard monofocal lens explicitly, request alternatives like monovision, and demand a written itemized quote before scheduling.

  • Many financial professionals are salespeople paid on what they push, not whether you end up wealthier. A fiduciary is the opposite. The SEC legally requires them to put your interests first. Advisor.com's free matching tool pairs you with vetted fiduciaries from major national firms, all in under three minutes. See who you match with today.

This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Cataract Surgery Is Covered Until the Surgeon Says “Premium Lens.” That One Word Costs About $3,000 an Eye.

© alvarez / E+ via Getty Images

A 68-year-old sits in the pre-op consult expecting Medicare to handle the whole thing. Cataract removal is one of the most common operations performed on Medicare beneficiaries. Then the surgeon slides a brochure across the desk: a “premium” lens that promises freedom from glasses, just $1,500 to $3,000 or more per eye. One signature adds a $5,000 out-of-pocket decision to a covered procedure, and Medicare will not reimburse a dollar of the upgrade.

This is the everyday billing trap in cataract care. The surgery itself is covered. The lens choice inside the surgery is where the bill splits in two.

What Medicare Actually Covers

Under Original Medicare in 2026, cataract surgery runs through Part B. After the annual Part B deductible, the patient owes 20% coinsurance on the Medicare-approved amount for the surgeon, the facility, and a standard monofocal intraocular lens (IOL). Medicare also pays for one pair of standard eyeglasses or contact lenses afterward, a rare eyewear benefit under Original Medicare. A Medigap Plan G absorbs the 20%. A Medicare Advantage plan runs it through the plan’s copay and out-of-pocket structure.

The monofocal lens corrects vision at one distance, usually far. Most patients still need reading glasses. That is the covered baseline, and for the great majority of cataract patients it works well.

The One Word That Costs $3,000 an Eye

Don’t let the messaging fool you. Premium is marketing shorthand, not Medicare’s technical category. CMS rulings 05-01 and 1536-R classify the presbyopia-correcting function of a multifocal IOL and the astigmatism-correcting function of a toric IOL as outside Medicare’s benefit category. Medicare pays what it would have paid for the standard lens and surgery. Everything above that price, including the upgraded functionality and related services beyond standard cataract care, is the patient’s responsibility.

Legally, the charges should be disclosed in advance. Because the premium functionality is excluded from Medicare by law, an ABN is not required, although a provider may use one voluntarily. Practically, the cost can still catch patients off guard because the conversation happens 10 minutes after a doctor explains why the patient needs surgery, and the patient is not in a shopping mindset.

Per-eye upgrade pricing typically lands at $1,500 to $3,000 or more. Both eyes at the higher end: roughly $6,000 out of pocket. Medigap does not pay it. Neither does Plan G. Medicare Advantage coverage depends on the plan. The charge sits outside the Medicare fee schedule entirely.

The Budget Context Nobody Mentions

A $6,000 lens decision lands in a household budget already stretched thin. Many Medicare beneficiaries live primarily on Social Security, leaving little room for a sudden elective expense. The saving rate fell to 2.8% in Q2 2026, while consumer sentiment remains 10.5% below last year. The 2.8% cost-of-living adjustment (COLA) offers limited relief. In that setting, the upgrade competes with housing, food, utilities, and every other expense the monthly benefit must cover.

When the Upgrade Is Actually Worth It

The premium lens can be a legitimate upgrade. For a patient with significant astigmatism who would otherwise wear glasses full-time after surgery, a toric IOL may deliver a real functional benefit. For a patient who reads a lot, wants less dependence on glasses, and understands the visual tradeoffs, a multifocal or extended-depth-of-focus lens can be worth the cost.

The trap is defaulting into the upgrade because the surgeon presents it as the better option and the patient assumes insurance will smooth the edges. Insurance generally will not. For someone happy with reading glasses, or for someone with mild astigmatism, the monofocal lens may do the job at Part B pricing.

What to Do Before You Sign

Do not make the lens decision while the brochure is still open. Take these three steps first.

  • Ask for the standard monofocal lens explicitly. Medicare covers the surgery and lens after the Part B deductible and 20% coinsurance. If a Medigap policy is in place, out-of-pocket costs may be modest.
  • Inquire about lower-cost alternatives to a toric lens. Glasses after surgery may correct astigmatism, while a monovision strategy uses standard lenses to set one eye for distance and one for near. Monovision is not suitable for everyone.
  • Demand a written itemized quote before agreeing to the upgrade. Insist on separate line items for the covered surgery, the covered monofocal lens, and each noncovered charge. Do not schedule until you understand exactly what you are buying.

A premium lens may be worth buying. It should never become a bill you discover Medicare did not cover after the surgery.

Contact [email protected] for any questions or corrections.

Photo of Gerelyn Terzo
About the Author Gerelyn Terzo →

Gerelyn Terzo is the author of dividend investing handbook "Dividend Investing Strategies: How to Have Your Cake & Eat It Too." A veteran financial journalist, she covers agri-finance for outlets like Global AgInvesting and the broader stock market and personal finance for 24/7 Wall Street. She began at CNBC and later helped launch Fox Business in New York. Gerelyn currently resides in Woodland Park, Colorado and dabbles in nature photography as a hobby.

Featured Reads

Our top personal finance-related articles today. Your wallet will thank you later.

Continue Reading

Top Gaining Stocks

CPRT Vol: 17,358,449
AMD
AMD Vol: 25,570,334
Fox
FOX Vol: 1,069,104
STX Vol: 5,246,750
Fox
FOXA Vol: 7,501,474

Top Losing Stocks

CTRA Vol: 73,319,495
AVGO Vol: 29,513,308
GDDY Vol: 2,085,032
AMAT Vol: 13,132,341
CRWD Vol: 6,750,293